Source:http://linkedlifedata.com/resource/pubmed/id/11123259
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-2-2
|
pubmed:abstractText |
Because little is known of the intracellular mechanisms involved in the vasoconstrictor effect of melatonin (Mel), we examined the in vitro effects of Mel by using perfused cylindrical segments of the rat tail artery loaded with the intracellular Ca(2+) concentration ([Ca(2+)](i))-sensitive fluorescent dye, fura 2. Mel (10(-14) to 10(-4) M) had no effect on baseline perfusion pressure or [Ca(2+)](i) but increased, at submicromolar concentrations, the vasoconstrictor effect of norepinephrine (NE) (P = 0.0029). Mel did not modify NE-induced [Ca(2+)](i) mobilization, and thus the [Ca(2+)](i) sensitivity of NE-induced contraction increased in the presence of Mel. Mel consistently increased KCl-induced vasoconstriction and [Ca(2+)](i) sensitivity of contraction, but differences were not statistically significant. In conclusion, Mel increases the [Ca(2+)](i) sensitivity of vasoconstriction evoked by NE suggesting that Mel may amplify endogenous vasoconstrictor responses to sympathetic outflow.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Melatonin,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Chloride,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0363-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
280
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H420-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11123259-Animals,
pubmed-meshheading:11123259-Antioxidants,
pubmed-meshheading:11123259-Arteries,
pubmed-meshheading:11123259-Blood Pressure,
pubmed-meshheading:11123259-Calcium,
pubmed-meshheading:11123259-Cytosol,
pubmed-meshheading:11123259-Drug Synergism,
pubmed-meshheading:11123259-Male,
pubmed-meshheading:11123259-Melatonin,
pubmed-meshheading:11123259-Norepinephrine,
pubmed-meshheading:11123259-Perfusion,
pubmed-meshheading:11123259-Potassium Chloride,
pubmed-meshheading:11123259-Rats,
pubmed-meshheading:11123259-Rats, Wistar,
pubmed-meshheading:11123259-Regional Blood Flow,
pubmed-meshheading:11123259-Signal Transduction,
pubmed-meshheading:11123259-Tail,
pubmed-meshheading:11123259-Vasoconstrictor Agents
|
pubmed:year |
2001
|
pubmed:articleTitle |
Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration.
|
pubmed:affiliation |
Laboratoire de Pharmacologie Cardiovasculaire, EA 3116, Faculté de Pharmacie, UHP-Nancy 1, 54001 Nancy Cedex, France.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|